Cargando…
Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era — China, 2017–2018
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Human papillomavirus (HPV) type-specific strategies play a key role in the prevention of cervical intraepithelial neoplasia (CIN), but evidence on the HPV type-specific prevalence in CIN is limited. WHAT IS ADDED BY THIS REPORT? This multicentric study estimat...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889231/ https://www.ncbi.nlm.nih.gov/pubmed/36751369 http://dx.doi.org/10.46234/ccdcw2022.218 |
_version_ | 1784880686314815488 |
---|---|
author | Bao, Heling Chen, Weihong Zhang, Xiaosong Bi, Hui Zhao, Yun Fang, Liwen Cong, Shu Tan, Feng Wang, Linhong |
author_facet | Bao, Heling Chen, Weihong Zhang, Xiaosong Bi, Hui Zhao, Yun Fang, Liwen Cong, Shu Tan, Feng Wang, Linhong |
author_sort | Bao, Heling |
collection | PubMed |
description | WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Human papillomavirus (HPV) type-specific strategies play a key role in the prevention of cervical intraepithelial neoplasia (CIN), but evidence on the HPV type-specific prevalence in CIN is limited. WHAT IS ADDED BY THIS REPORT? This multicentric study estimates the prevalence of high-risk HPV types in CIN cases and the associations of HPV infection patterns with high-grade CIN in China in 2017–2018. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? Population-based prevention strategies should give preference to HPV-16 and 18, and strategies for non-16/18 high-risk HPV are essential for the elimination of cervical cancer. |
format | Online Article Text |
id | pubmed-9889231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-98892312023-02-06 Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era — China, 2017–2018 Bao, Heling Chen, Weihong Zhang, Xiaosong Bi, Hui Zhao, Yun Fang, Liwen Cong, Shu Tan, Feng Wang, Linhong China CDC Wkly Preplanned Studies WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Human papillomavirus (HPV) type-specific strategies play a key role in the prevention of cervical intraepithelial neoplasia (CIN), but evidence on the HPV type-specific prevalence in CIN is limited. WHAT IS ADDED BY THIS REPORT? This multicentric study estimates the prevalence of high-risk HPV types in CIN cases and the associations of HPV infection patterns with high-grade CIN in China in 2017–2018. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? Population-based prevention strategies should give preference to HPV-16 and 18, and strategies for non-16/18 high-risk HPV are essential for the elimination of cervical cancer. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022-12-02 /pmc/articles/PMC9889231/ /pubmed/36751369 http://dx.doi.org/10.46234/ccdcw2022.218 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) |
spellingShingle | Preplanned Studies Bao, Heling Chen, Weihong Zhang, Xiaosong Bi, Hui Zhao, Yun Fang, Liwen Cong, Shu Tan, Feng Wang, Linhong Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era — China, 2017–2018 |
title | Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era — China, 2017–2018 |
title_full | Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era — China, 2017–2018 |
title_fullStr | Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era — China, 2017–2018 |
title_full_unstemmed | Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era — China, 2017–2018 |
title_short | Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era — China, 2017–2018 |
title_sort | prevalence of high-risk human papillomavirus in cervical intraepithelial neoplasia in the pre-vaccine era — china, 2017–2018 |
topic | Preplanned Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889231/ https://www.ncbi.nlm.nih.gov/pubmed/36751369 http://dx.doi.org/10.46234/ccdcw2022.218 |
work_keys_str_mv | AT baoheling prevalenceofhighriskhumanpapillomavirusincervicalintraepithelialneoplasiaintheprevaccineerachina20172018 AT chenweihong prevalenceofhighriskhumanpapillomavirusincervicalintraepithelialneoplasiaintheprevaccineerachina20172018 AT zhangxiaosong prevalenceofhighriskhumanpapillomavirusincervicalintraepithelialneoplasiaintheprevaccineerachina20172018 AT bihui prevalenceofhighriskhumanpapillomavirusincervicalintraepithelialneoplasiaintheprevaccineerachina20172018 AT zhaoyun prevalenceofhighriskhumanpapillomavirusincervicalintraepithelialneoplasiaintheprevaccineerachina20172018 AT fangliwen prevalenceofhighriskhumanpapillomavirusincervicalintraepithelialneoplasiaintheprevaccineerachina20172018 AT congshu prevalenceofhighriskhumanpapillomavirusincervicalintraepithelialneoplasiaintheprevaccineerachina20172018 AT tanfeng prevalenceofhighriskhumanpapillomavirusincervicalintraepithelialneoplasiaintheprevaccineerachina20172018 AT wanglinhong prevalenceofhighriskhumanpapillomavirusincervicalintraepithelialneoplasiaintheprevaccineerachina20172018 |